Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
Tóm tắt
The blood–brain barrier (BBB) is one of the most complex and selective barriers in the human organism. Its role is to protect the brain and preserve the homeostasis of the central nervous system (CNS). The central elements of this physical and physiological barrier are the endothelial cells that form a monolayer of tightly joined cells covering the brain capillaries. However, as endothelial cells regulate nutrient delivery and waste product elimination, they are very sensitive to signals sent by surrounding cells and their environment. Indeed, the neuro-vascular unit (NVU) that corresponds to the assembly of extracellular matrix, pericytes, astrocytes, oligodendrocytes, microglia and neurons have the ability to influence BBB physiology. Extracellular vesicles (EVs) play a central role in terms of communication between cells. The NVU is no exception, as each cell can produce EVs that could help in the communication between cells in short or long distances. Studies have shown that EVs are able to cross the BBB from the brain to the bloodstream as well as from the blood to the CNS. Furthermore, peripheral EVs can interact with the BBB leading to changes in the barrier’s properties. This review focuses on current knowledge and potential applications regarding EVs associated with the BBB.
Từ khóa
Tài liệu tham khảo
Peluffo, 2015, BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS, Biotechnol. Adv., 33, 277, 10.1016/j.biotechadv.2015.02.004
Saraiva, 2016, Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases, J. Control. Release, 235, 34, 10.1016/j.jconrel.2016.05.044
Karamanos, 2016, Proteomics and the blood–brain barrier: How recent findings help drug development, Expert Rev. Proteomics, 13, 251, 10.1586/14789450.2016.1143780
Cecchelli, 2007, Modelling of the blood-brain barrier in drug discovery and development, Nat. Rev. Drug Discov., 6, 650, 10.1038/nrd2368
Abbott, 2002, Astrocyte-endothelial interactions and blood-brain barrier permeability, J. Anat., 200, 629, 10.1046/j.1469-7580.2002.00064.x
Abbott, 2013, Blood-brain barrier structure and function and the challenges for CNS drug delivery, J. Inherit. Metab. Dis., 36, 437, 10.1007/s10545-013-9608-0
Muoio, 2014, The neurovascular unit - concept review, Acta Physiol. (Oxf)., 210, 790, 10.1111/apha.12250
Neuwelt, 2004, Mechanisms of disease: The blood-brain barrier, Neurosurgery, 54, 131, 10.1227/01.NEU.0000097715.11966.8E
McConnell, 2017, The translational significance of the neurovascular unit, J. Biol. Chem., 292, 762, 10.1074/jbc.R116.760215
Vandenbroucke, 2016, Into rather unexplored terrain-transcellular transport across the blood-brain barrier, Glia, 64, 1097, 10.1002/glia.22960
Haseloff, 2015, Transmembrane proteins of the tight junctions at the blood–brain barrier: Structural and functional aspects, Semin. Cell Dev. Biol., 38, 16, 10.1016/j.semcdb.2014.11.004
Dehouck, 1997, A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier, J. Cell Biol., 138, 877, 10.1083/jcb.138.4.877
Candela, 2010, Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by p-glycoprotein, J. Alzheimer’s Dis., 22, 849, 10.3233/JAD-2010-100462
Candela, 2013, Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells, Brain Res., 1517, 1, 10.1016/j.brainres.2013.04.008
Gosselet, 2013, Amyloid-β peptides, Alzheimer’s disease and the blood-brain barrier, Curr. Alzheimer Res., 10, 1015, 10.2174/15672050113106660174
Geevarghese, 2014, Pericyte-endothelial crosstalk: Implications and opportunities for advanced cellular therapies, Transl. Res., 163, 296, 10.1016/j.trsl.2014.01.011
Vandenhaute, 2016, Adapting coculture in vitro models of the blood-brain barrier for use in cancer research: Maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration, Lab. Investig., 96, 588, 10.1038/labinvest.2016.35
Sweeney, 2019, Blood-brain barrier: From physiology to disease and back, Physiol. Rev., 99, 21, 10.1152/physrev.00050.2017
Daneman, 2010, Pericytes are required for blood-brain barrier integrity during embryogenesis, Nature, 468, 562, 10.1038/nature09513
Yasuda, 2013, Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier, Drug Metab. Dispos., 41, 923, 10.1124/dmd.112.050344
Raposo, 2018, Shedding light on the cell biology of extracellular vesicles, Nat. Rev. Mol. Cell Biol., 19, 213, 10.1038/nrm.2017.125
Hill, 2014, Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles, J. Extracell. Vesicles, 3, 26913, 10.3402/jev.v3.26913
Witwer, 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, J. Extracell. Vesicles, 7, 1535750, 10.1080/20013078.2018.1535750
Mestdagh, 2017, EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research, Nat. Methods, 14, 228, 10.1038/nmeth.4185
Liao, 2019, Acetylcholinesterase is not a generic marker of extracellular vesicles, J. Extracell. Vesicles, 8, 1628592, 10.1080/20013078.2019.1628592
Albuquerque, 2017, Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases, J. Control. Release, 262, 247, 10.1016/j.jconrel.2017.07.001
Kalra, H., Simpson, R.J., Ji, H., Aikawa, E., Altevogt, P., Askenase, P., Bond, V.C., Borràs, F.E., Breakefield, X., and Budnik, V. (2012). Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation. PLoS Biol., 10.
Ha, 2016, Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: Current perspectives and future challenges, Acta Pharm. Sin. B, 6, 287, 10.1016/j.apsb.2016.02.001
Keerthikumar, 2016, ExoCarta: A Web-Based Compendium of Exosomal Cargo, J. Mol. Biol., 428, 688, 10.1016/j.jmb.2015.09.019
Hessvik, 2018, Current knowledge on exosome biogenesis and release, Cell. Mol. Life Sci., 75, 193, 10.1007/s00018-017-2595-9
Dozio, 2017, Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure, J. Extracell. Vesicles, 6, 1302705, 10.1080/20013078.2017.1302705
Batrakova, 2015, Using exosomes, naturally-equipped nanocarriers, for drug delivery, J. Control. Release, 219, 396, 10.1016/j.jconrel.2015.07.030
Kowal, 2016, Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes, Proc. Natl. Acad. Sci. USA, 113, E968, 10.1073/pnas.1521230113
Aalberts, 2012, Identification of Distinct Populations of Prostasomes That Differentially Express Prostate Stem Cell Antigen, Annexin A1, and GLIPR2 in Humans1, Biol. Reprod., 86, 82, 10.1095/biolreprod.111.095760
Siljander, 2015, Biological properties of extracellular vesicles and their physiological functions, J. Extracell. vesicles, 4, 27066, 10.3402/jev.v4.27066
Rocha, 2017, A Perspective on Extracellular Vesicles Proteomics, Front. Chem., 5, 102, 10.3389/fchem.2017.00102
Haqqani, 2013, Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells, Fluids Barriers CNS, 10, 4, 10.1186/2045-8118-10-4
Sweeney, 2016, V Pericytes of the neurovascular unit: Key functions and signaling pathways, Nat. Neurosci., 19, 771, 10.1038/nn.4288
Toborek, 2016, Extracellular vesicles of the blood-brain barrier, Tissue Barriers, 4, e1131804, 10.1080/21688370.2015.1131804
Weksler, 2005, Blood-brain barrier-specific properties of a human adult brain endothelial cell line, FASEB J., 19, 1872, 10.1096/fj.04-3458fje
Leda, 2017, Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology, Mol. Cell. Neurosci., 79, 12, 10.1016/j.mcn.2016.12.006
Chiasserini, 2014, Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset, J. Proteomics, 106, 191, 10.1016/j.jprot.2014.04.028
Colin, 2020, From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy, Acta Neuropathol., 139, 3, 10.1007/s00401-019-02087-9
Sinha, 2018, Proteomic Profiling of Secreted Proteins, Exosomes, and Microvesicles in Cell Culture Conditioned Media, Methods Mol. Biol., 1722, 91, 10.1007/978-1-4939-7553-2_6
Chiarini, 2017, Amyloid β-exposed human astrocytes overproduce phospho-tau and overrelease it within exosomes, effects suppressed by calcilytic NPS 2143-Further implications for Alzheimer’s therapy, Front. Neurosci., 11, 217, 10.3389/fnins.2017.00217
Xu, 2017, Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity, Cell Res., 27, 882, 10.1038/cr.2017.62
Yuan, 2019, Exosomes Derived From Pericytes Improve Microcirculation and Protect Blood–Spinal Cord Barrier After Spinal Cord Injury in Mice, Front. Neurosci., 13, 319, 10.3389/fnins.2019.00319
Balusu, 2016, Identification of a novel mechanism of blood-brain communication during peripheral inflammation via choroid plexus-derived extracellular vesicles, EMBO Mol. Med., 8, 1162, 10.15252/emmm.201606271
Matsumoto, 2017, Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: Another mechanism for initiation and progression of Parkinson’s disease?, Acta Neuropathol. Commun., 5, 71, 10.1186/s40478-017-0470-4
Chen, 2016, Elucidation of Exosome Migration across the Blood-Brain Barrier Model In Vitro, Cell. Mol. Bioeng., 9, 509, 10.1007/s12195-016-0458-3
Kuroda, 2019, Cluster of Differentiation 46 Is the Major Receptor in Human Blood-Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28), Mol. Pharm., 16, 292, 10.1021/acs.molpharmaceut.8b00985
Shi, 2014, Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease, Acta Neuropathol., 128, 639, 10.1007/s00401-014-1314-y
Fiandaca, 2015, Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study, Alzheimers. Dement., 11, 600, 10.1016/j.jalz.2014.06.008
Kapogiannis, 2015, Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease, FASEB J., 29, 589, 10.1096/fj.14-262048
Goetzl, 2016, Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease, FASEB J., 30, 4141, 10.1096/fj.201600816R
Goetzl, 2015, Low neural exosomal levels of cellular survival factors in Alzheimer’s disease, Ann. Clin. Transl. Neurol., 2, 769, 10.1002/acn3.211
Goetzl, 2018, Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer’s disease, FASEB J., 32, 888, 10.1096/fj.201700731R
Abner, 2016, Plasma neuronal exosomal levels of Alzheimer’s disease biomarkers in normal aging, Ann. Clin. Transl. Neurol., 3, 399, 10.1002/acn3.309
Hamlett, 2017, Neuronal exosomes reveal Alzheimer’s disease biomarkers in Down syndrome, Alzheimers. Dement., 13, 541, 10.1016/j.jalz.2016.08.012
Mullins, 2017, Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer’s disease, Hum. Brain Mapp., 38, 1933, 10.1002/hbm.23494
Winston, 2016, Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile, Alzheimer’s Dement. (Amsterdam, Netherlands), 3, 63
Selmaj, 2017, The role of exosomes in CNS inflammation and their involvement in multiple sclerosis, J. Neuroimmunol., 306, 1, 10.1016/j.jneuroim.2017.02.002
Alonso, 2017, DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients, Oncotarget, 8, 1416, 10.18632/oncotarget.13635
Tominaga, 2015, Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier, Nat. Commun., 6, 6716, 10.1038/ncomms7716
Paul, 2016, Appearance of claudin-5+ leukocytes in the central nervous system during neuroinflammation: A novel role for endothelial-derived extracellular vesicles, J. Neuroinflammation, 13, 292, 10.1186/s12974-016-0755-8
Gabathuler, 2010, Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases, Neurobiol. Dis., 37, 48, 10.1016/j.nbd.2009.07.028
2016, Exosomes as a potential novel therapeutic tools against neurodegenerative diseases, Pharmacol. Res., 113, 816, 10.1016/j.phrs.2016.02.002
Betzer, 2017, In Vivo Neuroimaging of Exosomes Using Gold Nanoparticles, ACS Nano, 11, 10883, 10.1021/acsnano.7b04495
Zhuang, 2011, Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain, Mol. Ther., 19, 1769, 10.1038/mt.2011.164
Lakhal, 2011, Intranasal exosomes for treatment of neuroinflammation?: Prospects and limitations, Mol. Ther., 19, 1754, 10.1038/mt.2011.198
Seow, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nat. Biotechnol., 29, 341, 10.1038/nbt.1807
Katakowski, 2016, Exosomes as Tools to Suppress Primary Brain Tumor, Cell. Mol. Neurobiol., 36, 343, 10.1007/s10571-015-0280-9
Bell, 2016, Designer exosomes as next-generation cancer immunotherapy, Nanomedicine, 12, 163, 10.1016/j.nano.2015.09.011
Sterzenbach, 2017, Engineered Exosomes as Vehicles for Biologically Active Proteins, Mol. Ther., 25, 1269, 10.1016/j.ymthe.2017.03.030
Baietti, 2012, Syndecan-syntenin-ALIX regulates the biogenesis of exosomes, Nat. Cell Biol., 14, 677, 10.1038/ncb2502
Mustapic, 2017, Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes, Front. Neurosci., 11, 278, 10.3389/fnins.2017.00278
2016, Extracellular Vesicles: Goodies for the Brain? 2016, 41, 371–372, Neuropsychopharmacology, 41, 371
Haney, 2015, Exosomes as drug delivery vehicles for Parkinson’s disease therapy, J. Control. Release, 207, 18, 10.1016/j.jconrel.2015.03.033
Lee, 2017, The Obstacles to Current Extracellular Vesicle-Mediated Drug Delivery Research, J. Pharm. Pharm., 4, 156